CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Sudarshan Pharma Industries Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Sudarshan Pharma Industries Ltd
Phone: +91 2242221111p:+91 2242221111 MUMBAI, 400092  India Ticker: 543828543828
Business Summary
Sudarshan Pharma Industries Limited is an India-based company, which is engaged in job work manufacturing in pharmaceutical items and traders in chemicals and solvents in India. The Company operates in the State of Maharashtra, Gujarat, Himachal Pradesh, and Uttarakhand. The Company is involved in specialty chemicals and intermediates for pharma, agriculture chemicals, coating, paints, adhesive, and various other industries. It is also into active pharmaceuticals ingredients manufacturing. It is also into specialty chemicals imports and exports, as well as supply of same to the actual users. The Company provides customize specialty chemicals to its clients in India and abroad regularly. The Company is also involved in contract manufacturing, outsource and supply of generic pharma formulation, and medicines to healthcare institution, government, non-governmental organization (NGO) and hospitals.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20233/31/2023-----

Industries
SIC Code Description
2834 Pharmaceutical preparations
5122 Drugs, drug proprietaries, and druggists' sundries
5169 Chemicals and allied products, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Managing Director, Executive Chairman of the Borad Hemal V.Mehta 46 11/8/2018 7/23/2008
Chief Financial Officer, Joint Managing Director, Executive Director Sachin V.Mehta 39 12/12/2023 7/23/2008
Head of Sales and Marketing of Pharma Division IndrarajNeogi 39 8/2/2017 8/2/2017
6 additional Officers and Directors records available in full report.

General Information
Number of Employees: 56 (As of 3/31/2023)
Outstanding Shares: 24,065,887 (As of 9/30/2023)
Shareholders: 1,246
Stock Exchange: BOM


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 28, 2024